At a glance
ClinicalIndex Comparison RecordN/ACompleted· 121 enrolled
Drug / intervention
Resorbable Meshdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Multi-Center Study of Phasix™ Mesh for Ventral or Incisional Hernia Repair.
In Brief
A clinical study evaluating Resorbable Mesh for Ventral Hernia and Incisional Hernia. Completed, enrolled 121 participants across 16 sites.
Detailed Summary
Single-arm study of Phasix Mesh in High Risk patients looking at SSI and recurrence rates.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVentral Hernia, Incisional Hernia
CountriesUnited States
CollaboratorsFGK Clinical Research GmbH
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartSep 2013
First PostedOct 2013
Primary CompletionJan 2020
TodayJul 2026
First PostedOct 11, 2013
Enrollment StartSep 1, 2013
Primary CompletionJan 27, 2020
TodayJul 2, 2026
Enrollment to primary: 6.4 yearsPosted 12.7 years ago
Interventions
Resorbable Meshdevice
Phasix Mesh